Top Suppliers:I want be here

87691-91-6

87691-91-6 structure
87691-91-6 structure
  • Name: Tiospirone
  • Chemical Name: 8-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]decane-7,9-dione
  • CAS Number: 87691-91-6
  • Molecular Formula: C24H32N4O2S
  • Molecular Weight: 440.60100
  • Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
  • Create Date: 2018-08-24 19:43:50
  • Modify Date: 2024-01-06 14:48:53
  • Tiospirone is a 5-HT2 receptor antagonist with affinity for D2, 5-HT1a, and 5-HT7, and sigma receptors. Tiospirone decreases consumption of ethanol while increasing food intake of rats. Tiospirone can also reduce the reinforcing properties of Cocaine exhibited in the conditioned place preference paradigm[1][2].

Name 8-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]decane-7,9-dione
Synonyms Tiospirona [Spanish]
tiaspirone
Tiospirone [INN]
Tiospironum [Latin]
[14C]-Tiospirone
Tiospironum
Tiospirona
8-{4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione
8-Azaspiro(4,5)decane-7,9-dione,8-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)
TIOSPIRONE
Description Tiospirone is a 5-HT2 receptor antagonist with affinity for D2, 5-HT1a, and 5-HT7, and sigma receptors. Tiospirone decreases consumption of ethanol while increasing food intake of rats. Tiospirone can also reduce the reinforcing properties of Cocaine exhibited in the conditioned place preference paradigm[1][2].
Related Catalog
References

[1]. Arolfo MP, et, al. Effects of amperozide and tiospirone, atypical antipsychotic 5-HT2 drugs, on food-reinforced behavior in rats. Physiol Behav. 1999 Dec;68(1-2):93-8.  

[2]. Arolfo MP, et, al. Tiospirone and the reinforcing effects of cocaine in the conditioned place preference paradigm in rats. J Pharm Pharmacol. 2000 Aug;52(8):977-81.  

Density 1.29g/cm3
Boiling Point 600.9ºC at 760 mmHg
Molecular Formula C24H32N4O2S
Molecular Weight 440.60100
Flash Point 317.2ºC
Exact Mass 440.22500
PSA 84.99000
LogP 3.84870
Index of Refraction 1.652

~89%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Mead Johnson and Company Patent: US4411901 A1, 1983 ;

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369

~%

87691-91-6 structure

87691-91-6

Literature: Yevich, Joseph P.; New, James S.; Smith, David W.; Lobeck, Walter G.; Catt, John D.; et al. Journal of Medicinal Chemistry, 1986 , vol. 29, # 3 p. 359 - 369